AAAAAA

   
Results: 1-7 |
Results: 7
Type 2 diabetes - preventable, but how?
Authors: Birkeland, KI Berg, JP
Citation: Ki. Birkeland et Jp. Berg, Type 2 diabetes - preventable, but how?, EUR J ENDOC, 145(5), 2001, pp. 573-575
Effect of rhEPO administration on serum levels of sTfR and cycling performance
Authors: Birkeland, KI Stray-Gundersen, J Hemmersbach, P Hallen, J Haug, E Bahr, R
Citation: Ki. Birkeland et al., Effect of rhEPO administration on serum levels of sTfR and cycling performance, MED SCI SPT, 32(7), 2000, pp. 1238-1243
Advanced glycation end products and coronary heart disease in type 2 diabetes - Response to Poirier and Eckel
Authors: Kilhovd, BK Berg, TJ Birkeland, KI Thorsby, P Hanssen, KF
Citation: Bk. Kilhovd et al., Advanced glycation end products and coronary heart disease in type 2 diabetes - Response to Poirier and Eckel, DIABET CARE, 23(9), 2000, pp. 1441-1442
Serum levels of advanced glycation end products are increased in patients with type 2 diabetes and coronary heart disease
Authors: Kilhovd, BK Berg, TJ Birkeland, KI Thorsby, P Hanssen, KF
Citation: Bk. Kilhovd et al., Serum levels of advanced glycation end products are increased in patients with type 2 diabetes and coronary heart disease, DIABET CARE, 22(9), 1999, pp. 1543-1548
The future of doping control in athletes - Issues related to blood sampling
Authors: Birkeland, KI Hemmersbach, P
Citation: Ki. Birkeland et P. Hemmersbach, The future of doping control in athletes - Issues related to blood sampling, SPORT MED, 28(1), 1999, pp. 25-33
Improving glycaemic control with current therapies
Authors: Birkeland, KI
Citation: Ki. Birkeland, Improving glycaemic control with current therapies, DIABET MED, 15(12), 1998, pp. S13-S19
Improving glycaemic control with current therapies
Authors: Birkeland, KI
Citation: Ki. Birkeland, Improving glycaemic control with current therapies, DIABET MED, 15(12), 1998, pp. S13-S19
Risultati: 1-7 |